A detailed history of Peak6 LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Peak6 LLC holds 7,100 shares of MRNA stock, worth $175,796. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,100
Previous 28,900 75.43%
Holding current value
$175,796
Previous $797,000 77.04%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

SELL
$23.51 - $34.67 $4.46 Million - $6.58 Million
-189,657 Reduced 60.37%
124,481 $3.22 Million
Q2 2025

Aug 13, 2025

BUY
$23.65 - $28.54 $1.16 Million - $1.4 Million
48,888 Added 18.43%
314,138 $8.67 Million
Q1 2025

May 14, 2025

BUY
$28.35 - $47.53 $3.19 Million - $5.35 Million
112,532 Added 73.69%
265,250 $7.52 Million
Q4 2024

Feb 13, 2025

BUY
$36.85 - $63.93 $5.63 Million - $9.76 Million
152,718 New
152,718 $6.35 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $9.69B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Peak6 LLC Portfolio

Follow Peak6 LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 LLC with notifications on news.